JP2006504653A5 - - Google Patents

Download PDF

Info

Publication number
JP2006504653A5
JP2006504653A5 JP2004522507A JP2004522507A JP2006504653A5 JP 2006504653 A5 JP2006504653 A5 JP 2006504653A5 JP 2004522507 A JP2004522507 A JP 2004522507A JP 2004522507 A JP2004522507 A JP 2004522507A JP 2006504653 A5 JP2006504653 A5 JP 2006504653A5
Authority
JP
Japan
Prior art keywords
seq
ghrelin
attachment site
antigen
antigenic determinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004522507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006504653A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/007849 external-priority patent/WO2004009124A2/en
Publication of JP2006504653A publication Critical patent/JP2006504653A/ja
Publication of JP2006504653A5 publication Critical patent/JP2006504653A5/ja
Pending legal-status Critical Current

Links

JP2004522507A 2002-07-19 2003-07-18 グレリン−担体複合体 Pending JP2006504653A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39663802P 2002-07-19 2002-07-19
PCT/EP2003/007849 WO2004009124A2 (en) 2002-07-19 2003-07-18 Ghrelin-carrier conjugates

Publications (2)

Publication Number Publication Date
JP2006504653A JP2006504653A (ja) 2006-02-09
JP2006504653A5 true JP2006504653A5 (https=) 2010-04-02

Family

ID=30770928

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004522507A Pending JP2006504653A (ja) 2002-07-19 2003-07-18 グレリン−担体複合体

Country Status (16)

Country Link
US (1) US20040076645A1 (https=)
EP (1) EP1523372B1 (https=)
JP (1) JP2006504653A (https=)
KR (1) KR20050027168A (https=)
CN (1) CN1665565A (https=)
AT (1) ATE441429T1 (https=)
BR (1) BR0311800A (https=)
CA (1) CA2489008A1 (https=)
DE (1) DE60329106D1 (https=)
IL (1) IL165003A (https=)
MX (1) MXPA04011247A (https=)
NZ (1) NZ537001A (https=)
PL (1) PL375522A1 (https=)
RU (1) RU2325202C2 (https=)
WO (1) WO2004009124A2 (https=)
ZA (1) ZA200408894B (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2407897A1 (en) * 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
CA2488856A1 (en) * 2002-06-20 2003-12-31 Cytos Biotechnology Ag Packaged virus-like particles for use as adjuvants: method of preparation and use
NZ537003A (en) * 2002-07-18 2008-03-28 Cytos Biotechnology Ag Hapten-carrier conjugates comprising virus like particles and uses thereof
SI1524994T1 (sl) * 2002-07-19 2011-08-31 Cytos Biotechnology Ag Sestavki cepiv, ki vsebujejo amiloidne beta 1-6 antigenske mreĹľe
WO2004027064A2 (en) * 2002-09-18 2004-04-01 Centre Hospitalier De L'universite De Montreal (Chum) Ghrh analogues
EP1605972A2 (en) 2003-03-26 2005-12-21 Cytos Biotechnology AG Hiv-peptide-carrier-conjugates
EP1706152A2 (en) * 2004-01-20 2006-10-04 Cytos Biotechnology AG Particle-induced ghrelin immune response
GB0411014D0 (en) * 2004-05-18 2004-06-23 Haptogen Ltd Methods for the control treatment and management of obesity
WO2006037787A2 (en) 2004-10-05 2006-04-13 Cytos Biotechnology Ag Vlp-antigen conjugates and their uses as vaccines
NZ554386A (en) * 2004-10-25 2009-12-24 Cytos Biotechnology Ag Gastric inhibtory polypeptide (GIP) antigen arrays with VLPs and uses thereof
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
MX2007006832A (es) * 2004-12-13 2007-08-07 Cytos Biotechnology Ag Arreglos de antigeno interleucina 15 y usos de los mismos.
EP1868642B1 (en) 2005-03-18 2013-05-08 Cytos Biotechnology AG Cat allergen fusion proteins and uses thereof
US20090130130A1 (en) * 2005-06-10 2009-05-21 National University Of Singapore Mutant allergen(s)
EP1736538A1 (en) 2005-06-21 2006-12-27 Cytos Biotechnology AG Process for the preparative purification of virus-like-particles (VLPs)
CN101267834B (zh) 2005-09-28 2013-06-05 赛托斯生物技术公司 白介素-1偶联物及其用途
EP1973608A1 (en) 2005-12-14 2008-10-01 Cytos Biotechnology AG Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
BRPI0621298A2 (pt) * 2006-02-03 2012-10-09 Hills Pet Nutrition Inc métodos para avaliar a função renal de felinos, para diagnosticar doença renal em um felino, para detectar o inìcio da doença renal em um felino, para selecionar um regime para um felino, e para avaliar a eficácia de um regime para o controle da função renal em um felino, kit de diagnóstico, e, meio para a comunicação de informação
ATE493953T1 (de) * 2006-02-09 2011-01-15 Alain Dibie System zur behandlung von läsionen an einer blutgefässgabelung
US8992928B2 (en) * 2006-02-11 2015-03-31 Victor Raso Isolated monoclonal antibody or antigen-binding fragment that cleaves octanoylated native ghrelin
MX2008015529A (es) 2006-06-12 2009-01-13 Cytos Biotechnology Ag Procesos para empacar oligonucleotidos en particulas similares a virus de bacteriofagos de arn.
JP2009545618A (ja) * 2006-08-01 2009-12-24 ザ スクリップス リサーチ インスティテュート 脂肪蓄積制御のためのワクチンおよび方法
JP2010096677A (ja) * 2008-10-17 2010-04-30 Toray Ind Inc 抗体/抗原結合能を有する高感度免疫学測定用ナノ粒子
PL222496B1 (pl) * 2009-04-10 2016-08-31 Inst Biochemii I Biofizyki Pan Wektorowa cząsteczka wirusopodobna, sposób jej wytwarzania oraz kompozycja farmaceutyczna zawierająca wektorową cząsteczkę wirusopodobną
CA2761901C (en) 2009-05-12 2019-08-13 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
EP2493910A1 (en) 2009-10-30 2012-09-05 Tranzyme Pharma, Inc. Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
EP2582715B1 (en) * 2010-06-16 2018-11-28 The Administrators of the Tulane Educational Fund Growth hormone secretatogue receptor antagonists and uses thereof
WO2013092720A1 (en) 2011-12-22 2013-06-27 F. Hoffmann-La Roche Ag Full length antibody display system for eukaryotic cells and its use
CN108524919A (zh) 2012-05-17 2018-09-14 延伸生物科学股份有限公司 用于改进的药物递送的载体
US9789197B2 (en) 2014-10-22 2017-10-17 Extend Biosciences, Inc. RNAi vitamin D conjugates
WO2016065052A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Insulin vitamin d conjugates
US9585934B2 (en) 2014-10-22 2017-03-07 Extend Biosciences, Inc. Therapeutic vitamin D conjugates
WO2016112921A1 (en) 2015-01-15 2016-07-21 University Of Copenhagen Virus-like particle with efficient epitope display
ES2854726T3 (es) 2015-10-30 2021-09-22 The Univ Of Copenhagen Partícula similar a virus con presentación eficiente de epítopos
CN107253984B (zh) * 2017-05-08 2020-09-01 河南金大众生物工程有限公司 促生长复合多肽及其应用
CN112876535B (zh) * 2021-02-08 2023-06-30 浙江华缔药业集团医药开发有限公司 生物活性多肽及其应用
WO2023224236A1 (ko) * 2022-05-18 2023-11-23 한국과학기술원 면역 회피 효능이 강화된 박테리오파지
EP4593867A2 (en) 2022-09-30 2025-08-06 Extend Biosciences, Inc. Long-acting parathyroid hormone

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH512848A (de) * 1970-02-25 1971-09-15 Bbc Brown Boveri & Cie Spulenwicklung und Verfahren zu deren Herstellung
US4918166A (en) * 1987-04-10 1990-04-17 Oxford Gene Systems Limited Particulate hybrid HIV antigens
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
EP1690934A3 (en) * 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
GB9213601D0 (en) * 1992-06-26 1992-08-12 Mastico Robert A Protein based delivery system
US5935821A (en) * 1995-01-17 1999-08-10 Board Of Trustees Of The University Of Kentucky Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US6627729B1 (en) * 1997-03-24 2003-09-30 Zymogenetics, Inc. TML peptides
US6291653B1 (en) * 1997-03-24 2001-09-18 Zymogenetics, Inc. Antibodies to motilin homologs
NZ512456A (en) * 1998-11-30 2003-10-31 Cytos Biotechnology Ag Ordered molecular presentation of antigens
US6420521B1 (en) * 1999-06-30 2002-07-16 Zymogenetics, Inc. Short gastrointestinal peptides
KR100827973B1 (ko) * 1999-07-23 2008-05-21 겐지 간가와 신규 펩티드
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
US6527165B1 (en) * 2000-03-24 2003-03-04 General Electric Company Method of making an environmental resistant brazed assembly including a wear resistant surface portion
CA2407897A1 (en) * 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
CA2411667A1 (en) * 2000-05-30 2001-12-06 Merck & Co. Inc. Ghrelin analogs
US20020187938A1 (en) * 2000-07-24 2002-12-12 Romano Deghenghi Ghrelin antagonists
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
AU2002339224B2 (en) * 2001-09-14 2008-10-09 Kuros Us Llc Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
EP1432443B1 (en) * 2001-10-05 2009-01-21 Cytos Biotechnology AG Angiotensin peptide-carrier conjugates and uses thereof
ATE412428T1 (de) * 2001-11-07 2008-11-15 Cytos Biotechnology Ag Antigen-raster enthaltend rankl zur behandlung von knochenerkrankungen
WO2003040164A2 (en) * 2001-11-07 2003-05-15 Cytos Biotechnology Ag Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
US7485620B2 (en) * 2001-12-18 2009-02-03 Alizé Pharma SAS Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof

Similar Documents

Publication Publication Date Title
JP2006504653A5 (https=)
RU2005104565A (ru) Конъюгаты грелин-носитель
JP6088123B2 (ja) ワクチンとして有用な自己会合ペプチドナノ粒子
DK2590675T3 (en) ANTI-ANTI-COMPOSITIONS AND PROCEDURES FOR RESPIRATORY SYNCYTIAL VIRUS
IL166227A0 (en) Vaccine compositions containing amyloid beta1-6 antigen arrays
RU2005104235A (ru) Молекулярные массивы антигенов
JP2008517975A (ja) 胃酸分泌抑制ポリペプチド(gip)抗原アッセイ及びその使用
JP2005532276A (ja) 免疫化組成物およびアミロイド前駆体タンパク質のβ−セクレターゼ開裂部位に対する免疫応答を誘発する方法
WO2003039225A3 (en) Antigen arrays comprising rankl for treatment of bone disease
JP2006504644A5 (https=)
Ding et al. Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2
CN1056816A (zh) 改良的疫苗组合物
CN105198982B (zh) 基于il-6的抗原表位及其应用
WO2003059386A3 (en) Prion protein carrier-conjugates
CN1338310A (zh) 一种猪瘟病毒表位疫苗及其制备方法
JP2025537236A (ja) アレルギー治療用ワクチン
CN1446094A (zh) 获得可增强特异交叉反应性的抗原结构的方法
JP5832904B2 (ja) βヘマチンを含むアジュバント
JP2022511995A5 (https=)
MXPA04003900A (es) Disposiciones de antigenos para el tratamiento de enfermedades oseas.
JP2005512987A5 (https=)
CN119894531A (zh) Tau肽免疫原构建体
JPWO2020072428A5 (https=)
KR20180040900A (ko) 산화아연 결합 펩티드 서열, 이를 포함하는 복합체, 및 상기 복합체를 포함하는 약학 조성물